Your browser doesn't support javascript.
loading
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
Nomoto, Hidetoshi; Kutsuna, Satoshi; Okuma, Kazu; Kuramitsu, Madoka; Tezuka, Kenta; Ikebe, Emi; Saito, Sho; Kinoshita, Noriko; Terada, Mari; Endo, Mio; Suzuki, Tetsuya; Miyazato, Yusuke; Nakamoto, Takato; Inada, Makoto; Hamaguchi, Isao; Ohmagari, Norio.
Afiliación
  • Nomoto H; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
  • Kutsuna S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: skutsuna@hosp.ncgm.go.jp.
  • Okuma K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kuramitsu M; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Tezuka K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ikebe E; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
  • Kinoshita N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan; Antimicrobial Resistance Clinical Reference Center, National Center for Global Health and M
  • Terada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Endo M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan.
  • Miyazato Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Nakamoto T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Inada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Hamaguchi I; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan; Antimicrobial Resistance Clinical Reference Center, National Center for Global Health and M
J Infect Chemother ; 27(4): 653-655, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33487533

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Viral / SARS-CoV-2 / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Viral / SARS-CoV-2 / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos